Triatomic Q4 2024 Private
The Q4 2024 investor letter from Triatomic Capital, dated January 31 2025, provides a comprehensive overview of the firm’s market outlook, investment activity, and portfolio performance. It begins with a macro‑level assessment of the venture climate, noting divergent trends where foundational model companies enjoy high valuations while many sectors face pressure, and reiterates Triatomic’s thesis that value will accrue to data and data‑infrastructure rather than algorithms. The letter then focuses on two strategic themes: (1) the shift toward custom AI compute and specialized silicon, driven by supply‑chain margin stacking, the “Nvidia tax,” and hyperscalers’ move to in‑house chips; it details ASIC announcements, supply‑chain economics, and analogizes the trend to Amazon’s logistics investment. (2) the emergence of 3‑D world models as the next frontier for AI, highlighting applications, compute demands, and the potential for spatially aware agents. The firm reports portfolio metrics (10 companies, 38 % engineered biology, 24 % next‑gen compute, etc.), a successful acqui‑hire of Betteromics (recovering ~92 % of capital), and a pipeline of 712 opportunities with 4 term‑sheet extensions. New investments include MatX (rack‑scale AI computer) and iPronics (programmable optical networking). Detailed updates on portfolio companies (Manifold Bio, Chemify, Lyten, dMatrix, Elegen, Teleo, etc.) are provided, along with recruitment needs and a request for AI tool leads. The letter concludes with standard legal disclosures. Throughout, the tone is analytical and cautiously optimistic, emphasizing strategic positioning in hardware and 3‑D AI while acknowledging market uncertainties.
Topics
Venture Landscape Contrast & Data‑Infrastructure Thesis
Analysis of 2024 venture dynamics, highlighting valuation divergence between foundational model firms and other sectors, and Triatomic’s belief that data and infrastructure will capture lasting value.